A COMBINATION OF ORAL AND TOPICAL BETA‐BLOCKERS WITH ADDITIVE EFFECTS ON INTRAOCULAR PRESSURE
Arne Öhrström, ÖRJAN KÄTTSTRÖM
Abstract
Arne Öhrström, ÖRJAN KÄTTSTRÖM
Abstract
In a double-masked randomised cross-over study the effect of adding oral propranolol (40 mg X 2) to topical timolol-treatment (0.5% X 2) was evaluated. Ten patients with glaucoma or ocular hypertension (totally 15 pathological eyes and 5 healthy) who had had topical timolol for at least 2 months received the coded oral treatment. A significant decrease of the intraocular pressure (3.68 +/- 0.72 SD, P less than 0.01) was observed in the timolol-treated eyes after the addition of the masked treatment with placebo/propranolol. Also the non-timolol-treated fellow eyes had a significant decrease of the intraocular pressure. It is suggested that this additive effects depends on a loss of efficacy of the topical beta-blocker caused by an increase in the number of beta-receptors and that the oral beta-blocker restores the degree of blocking to a more efficient level.
OpenAlex reports 4 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
In a double-masked randomised cross-over study the effect of adding oral propranolol (40 mg X 2) to topical timolol-treatment (0.5% X 2) was evaluated. Ten patients with glaucoma or ocular hypertension (totally 15 pathological eyes and 5 healthy) who had had topical timolol for at least 2 months received the coded oral treatment. A significant decrease of the intraocular pressure (3.68 +/- 0.72 SD, P less than 0.01) was observed in the timolol-treated eyes after the addition of the masked treatment with placebo/propranolol. Also the non-timolol-treated fellow eyes had a significant decrease of the intraocular pressure. It is suggested that this additive effects depends on a loss of efficacy of the topical beta-blocker caused by an increase in the number of beta-receptors and that the oral beta-blocker restores the degree of blocking to a more efficient level.
Key concepts: Timolol, Medicine, Intraocular pressure, Propranolol, Ocular hypertension, Placebo, Glaucoma, Ophthalmology